{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T16:00:34Z","timestamp":1769443234207,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004621","name":"Kerman University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["93013457"],"award-info":[{"award-number":["93013457"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.peptides.2019.05.003","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T21:11:30Z","timestamp":1558386690000},"page":"170091","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Apelin-13 attenuates motor impairments and prevents the changes in synaptic plasticity-related molecules in the striatum of Parkinsonism rats"],"prefix":"10.1016","volume":"117","author":[{"given":"Elham","family":"Haghparast","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Sheibani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Abbasnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5550-9806","authenticated-orcid":false,"given":"Saeed","family":"Esmaeili-Mahani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2019.05.003_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archneur.62.3.353","article-title":"Molecular pathogenesis of Parkinson disease","volume":"62","author":"Eriksen","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.peptides.2019.05.003_bib0010","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/mds.23732","article-title":"Etiology and pathogenesis of Parkinson\u2019s disease","volume":"26","author":"Schapira","year":"2011","journal-title":"Mov. Disord."},{"key":"10.1016\/j.peptides.2019.05.003_bib0015","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/nrneurol.2013.10","article-title":"Cerebrospinal fluid biomarkers in Parkinson disease","volume":"9","author":"Parnetti","year":"2013","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.peptides.2019.05.003_bib0020","first-page":"553","article-title":"Synaptic dysfunction in Parkinson\u2019s disease, synaptic plasticity","author":"Picconi","year":"2012","journal-title":"Springer"},{"key":"10.1016\/j.peptides.2019.05.003_bib0025","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.neuro.051508.135422","article-title":"Physiology and pharmacology of striatal neurons","volume":"32","author":"Kreitzer","year":"2009","journal-title":"Ann. Rev. Neurosci."},{"key":"10.1016\/j.peptides.2019.05.003_bib0030","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/nn.3743","article-title":"Direct and indirect pathways of basal ganglia: a critical reappraisal","volume":"17","author":"Calabresi","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.peptides.2019.05.003_bib0035","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1172\/JCI59426","article-title":"PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking","volume":"122","author":"Porras","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.peptides.2019.05.003_bib0040","doi-asserted-by":"crossref","first-page":"20196","DOI":"10.1074\/jbc.M213140200","article-title":"Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors","volume":"278","author":"Fiorentini","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.05.003_bib0045","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neuroscience.2010.03.034","article-title":"Dopamine D1 and N-methyl-D-aspartate receptors and extracellular signal-regulated kinase mediate neuronal morphological changes induced by repeated cocaine administration","volume":"168","author":"Ren","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2019.05.003_bib0050","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/j.bcp.2008.01.018","article-title":"Dopaminergic signaling in dendritic spines","volume":"75","author":"Yao","year":"2008","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.peptides.2019.05.003_bib0055","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1523\/JNEUROSCI.21-05-01501.2001","article-title":"Hippocampal synaptic plasticity involves competition between Ca2+\/calmodulin-dependent protein kinase II and postsynaptic density 95 for binding to the NR2A subunit of the NMDA receptor","volume":"21","author":"Gardoni","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.05.003_bib0060","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/j.biopha.2017.01.159","article-title":"Neurosteroid allopregnanolone attenuates motor disability and prevents the changes of neurexin 1 and postsynaptic density protein 95 expression in the striatum of 6-OHDA-induced rats\u2019 model of Parkinson\u2019s disease","volume":"88","author":"Nezhadi","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.peptides.2019.05.003_bib0065","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1471-4159.2000.0740169.x","article-title":"Altered interaction between PSD\u201095 and the NMDA receptor following transient global ischemia","volume":"74","author":"Takagi","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.05.003_bib0070","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neulet.2011.11.035","article-title":"Differentially expressed gene profile in the 6-hydroxy-dopamine-induced cell culture model of Parkinson\u2019s disease","volume":"507","author":"Noelker","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.peptides.2019.05.003_bib0075","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.neuron.2004.10.013","article-title":"State-dependent calcium signaling in dendritic spines of striatal medium spiny neurons","volume":"44","author":"Carter","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.peptides.2019.05.003_bib0080","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1073\/pnas.0813361106","article-title":"Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson\u2019s disease: critical role for the astrocyte","volume":"106","author":"Chen","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.peptides.2019.05.003_bib0085","doi-asserted-by":"crossref","DOI":"10.1038\/srep24939","article-title":"Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer\u2019s disease","volume":"6","author":"Aytan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.peptides.2019.05.003_bib0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.peptides.2019.05.003_bib0095","first-page":"105","article-title":"Orphan seven transmembrane receptor screening, GPCRs: from deorphanization to lead structure identification","author":"Wigglesworth","year":"2007","journal-title":"Springer"},{"key":"10.1016\/j.peptides.2019.05.003_bib0100","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000054609","article-title":"Cloning, pharmacological characterization and brain distribution of the rat apelin receptor","volume":"72","author":"De Mota","year":"2000","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.peptides.2019.05.003_bib0105","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1046\/j.1471-4159.2003.01587.x","article-title":"Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin","volume":"84","author":"Medhurst","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.05.003_bib0110","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.peptides.2011.08.006","article-title":"Up-regulation of apelin in brain tissue of patients with epilepsy and an epileptic rat model","volume":"32","author":"Zhang","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2019.05.003_bib0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087421","article-title":"Mechanisms involved in dual vasopressin\/apelin neuron dysfunction during aging","volume":"9","author":"Sauvant","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.05.003_bib0120","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.npep.2018.01.001","article-title":"Apelin-13 ameliorates cognitive impairments in 6-hydroxydopamine-induced substantia nigra lesion in rats","volume":"68","author":"Haghparast","year":"2018","journal-title":"Neuropeptides"},{"issue":"2","key":"10.1016\/j.peptides.2019.05.003_bib0125","first-page":"116","article-title":"Protective effect of neuropeptide apelin-13 on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y dopaminergic cells: involvement of its antioxidant and antiapoptotic properties","volume":"20","author":"Pouresmaeili-Babaki","year":"2017","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.peptides.2019.05.003_bib0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0197-4580(00)82406-9","article-title":"Pathology of parkinsonism","volume":"21","author":"Jellinger","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.peptides.2019.05.003_bib0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neulet.2016.06.046","article-title":"The neuroprotective effect of apelin-13 in a mouse model of intracerebral hemorrhage","volume":"628","author":"Bao","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.peptides.2019.05.003_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023968","article-title":"Apelin deficiency accelerates the progression of amyotrophic lateral sclerosis","volume":"6","author":"Kasai","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.peptides.2019.05.003_bib0145","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.neuroscience.2004.08.007","article-title":"Behavioral, neuroendocrine and thermoregulatory actions of apelin-13","volume":"129","author":"Jaszberenyi","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2019.05.003_bib0150","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.brainresbull.2012.06.003","article-title":"Centrally administered apelin-13 induces depression-like behavior in mice","volume":"88","author":"Lv","year":"2012","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.peptides.2019.05.003_bib0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0006-8993(93)90576-9","article-title":"Correlation of apomorphine-and amphetamine-induced turning with nigrostriatal dopamine content in unilateral 6-hydroxydopamine lesioned rats","volume":"626","author":"Hudson","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.peptides.2019.05.003_bib0160","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2004.11.035","article-title":"Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins","volume":"119","author":"Graf","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.peptides.2019.05.003_bib0165","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1523\/JNEUROSCI.16-08-02488.1996","article-title":"CASK: a novel dlg\/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins","volume":"16","author":"Hata","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.05.003_bib0170","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nn1074","article-title":"Neurexin mediates the assembly of presynaptic terminals","volume":"6","author":"Dean","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.peptides.2019.05.003_bib0175","doi-asserted-by":"crossref","first-page":"17312","DOI":"10.1074\/jbc.M413812200","article-title":"Neuroligins mediate excitatory and inhibitory synapse formation involvement of PSD-95 and neurexin-1\u03b2 in neuroligin-induced synaptic specificity","volume":"280","author":"Levinson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.05.003_bib0180","doi-asserted-by":"crossref","first-page":"13915","DOI":"10.1073\/pnas.0405939101","article-title":"A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin","volume":"101","author":"Prange","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.peptides.2019.05.003_bib0185","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.1074\/jbc.274.9.5782","article-title":"Interaction of NE-dlg\/SAP102, a neuronal and endocrine tissue-specific membrane-associated guanylate kinase protein, with calmodulin and PSD-95\/SAP90 a possible regulatory role in molecular clustering at synaptic sites","volume":"274","author":"Masuko","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.peptides.2019.05.003_bib0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/24790","article-title":"Enhanced long-term potentiation and impaired learning in mice with mutant postsynaptic density-95 protein","volume":"396","author":"Migaud","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2019.05.003_bib0195","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1126\/science.284.5421.1845","article-title":"Specific coupling of NMDA receptor activation to nitric oxide neurotoxicity by PSD-95 protein","volume":"284","author":"Sattler","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.peptides.2019.05.003_bib0200","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.str.2012.12.014","article-title":"Supertertiary structure of the MAGUK core from PSD-95","volume":"21","author":"Zhang","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.peptides.2019.05.003_bib0205","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/j.1471-4159.2011.07383.x","article-title":"NMDA receptor modulation by the neuropeptide apelin: implications for excitotoxic injury","volume":"118","author":"Cook","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.05.003_bib0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0079-6123(10)83004-3","article-title":"What causes the death of dopaminergic neurons in Parkinson\u2019s disease?","author":"Surmeier","year":"2010","journal-title":"Prog. Brain Res. Elsevier"},{"key":"10.1016\/j.peptides.2019.05.003_bib0215","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/BST0380493","article-title":"Synaptic dysfunction in Parkinson\u2019s disease","volume":"38","author":"Vincenza","year":"2010","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.peptides.2019.05.003_bib0220","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1124\/jpet.105.091074","article-title":"A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2\/3 receptor agonist in mouse models predictive of antipsychotic activity","volume":"315","author":"Galici","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2019.05.003_bib0225","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.neuropharm.2012.03.029","article-title":"The metabotropic glutamate receptor 8 agonist (S)-3, 4-DCPG reverses motor deficits in prolonged but not acute models of Parkinson\u2019s disease","volume":"66","author":"Johnson","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.peptides.2019.05.003_bib0230","doi-asserted-by":"crossref","first-page":"7218","DOI":"10.1523\/JNEUROSCI.23-18-07218.2003","article-title":"Group III metabotropic glutamate receptor-mediated modulation of the striatopallidal synapse","volume":"23","author":"Valenti","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.05.003_bib0235","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1124\/jpet.102.033266","article-title":"Dopamine modulates the function of group II and group III metabotropic glutamate receptors in the substantia nigra pars reticulata","volume":"302","author":"Wittmann","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.peptides.2019.05.003_bib0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jphs.2016.12.002","article-title":"Apelin protects against NMDA-induced retinal neuronal death via an APJ receptor by activating Akt and ERK1\/2, and suppressing TNF-\u03b1 expression in mice","volume":"133","author":"Ishimaru","year":"2017","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.peptides.2019.05.003_bib0245","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1471-4159.2007.04645.x","article-title":"Apelin, an endogenous neuronal peptide, protects hippocampal neurons against excitotoxic injury","volume":"102","author":"O\u2019Donnell","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.peptides.2019.05.003_bib0250","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/j.yexcr.2010.02.005","article-title":"Neuroprotective effect of the endogenous neural peptide apelin in cultured mouse cortical neurons","volume":"316","author":"Zeng","year":"2010","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.peptides.2019.05.003_bib0255","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1523\/JNEUROSCI.4574-04.2005","article-title":"Metabotropic glutamate receptors and dopamine receptors cooperate to enhance extracellular signal-regulated kinase phosphorylation in striatal neurons","volume":"25","author":"Voulalas","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.peptides.2019.05.003_bib0260","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.peptides.2012.07.012","article-title":"Neuroprotection of apelin and its signaling pathway","volume":"37","author":"Cheng","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2019.05.003_bib0265","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1139\/bcb-2014-0072","article-title":"The apelin receptor: physiology, pathology, cell signalling, and. ligand modulation of a peptide-activated class A GPCR","volume":"92","author":"Chapman","year":"2014","journal-title":"Biochem. Cell Biol."}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119300634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978119300634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T13:47:08Z","timestamp":1762264028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978119300634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":53,"alternative-id":["S0196978119300634"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2019.05.003","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apelin-13 attenuates motor impairments and prevents the changes in synaptic plasticity-related molecules in the striatum of Parkinsonism rats","name":"articletitle","label":"Article Title"},{"value":"Peptides","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.peptides.2019.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"170091"}}